Breakthroughs in hereditary angioedema management: a systematic review of approved drugs and those under research

Hereditary angioedema (HAE) is a rare genetic disorder, characterized by recurrent and unexpected potentially life-threatening mucosal swelling. The impairment underlying HAE could be a defect in C1-inhibitor activity, or in its serum concentration. Patients affected by HAE should be treated with on...

Descripción completa

Detalles Bibliográficos
Autores principales: Nicola, Stefania, Rolla, Giovanni, Brussino, Luisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioExcel Publishing Ltd 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6788388/
https://www.ncbi.nlm.nih.gov/pubmed/31645881
http://dx.doi.org/10.7573/dic.212605

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6788388/
https://www.ncbi.nlm.nih.gov/pubmed/31645881
http://dx.doi.org/10.7573/dic.212605

Ejemplares similares